A Reagentless, Screen-Printed Amperometric Biosensor for the Determination of Glutamate in Food and Clinical Applications.

A reagentless biosensor has been successfully developed to measure glutamate in food and clinical samples. The enzyme, glutamate dehydrogenase (GLDH) and the cofactor, nicotinamide adenine dinucleotide (NAD+) are fully integrated onto the surface of a Meldola's Blue screen-printed carbon electrode (MB-SPCE). The biological components are immobilized by utilizing unpurified multi-walled carbon nanotubes (MWCNT's) mixed with the biopolymer chitosan (CHIT), which are drop-coated onto the surface of the MB-SPCE in a layer-by-layer fashion. Meldola's Blue mediator is also incorporated into the biosensor cocktail in order to increase and facilitate electron shuttling between the reaction layers and the surface of the electrode. The loadings of each component are optimized by using amperometry in stirred solution at a low fixed potential of +0.1 V. The optimum temperature and pH are also determined using this technique. Quantification of glutamate in real samples is performed using the method of standard addition. The method of standard addition involves the addition of a sample containing an unknown concentration of glutamate, followed by additions of known concentrations of glutamate to a buffered solution in the cell. The currents generated by each addition are then plotted and the resulting line is extrapolated in order to determine the concentration of glutamate in the sample (Pemberton et al., Biosens Bioelectron 24:1246-1252, 2009). This layer-by-layer approach holds promise as a generic platform for the fabrication of reagentless biosensors.

A novel reagentless glutamate microband biosensor for real-time cell toxicity monitoring.

A reagentless glutamate biosensor was applied to the determination of glutamate released from liver hepatocellular carcinoma cells (HepG2) in response to toxic challenge from various concentrations of paracetamol. A screen printed carbon electrode (SPCE) containing the electrocatalyst Meldola's Blue (MB-SPCE) served as the electron mediator for the oxidation of NADH. A mixture of the enzyme glutamate dehydrogenase (GLDH), cofactor nicotinamide adenine dinucleotide (NAD(+)) and the biopolymer chitosan (CHIT) were drop-coated onto the surface of the transducer (MB-SPCE) in a simple one step fabrication process. The reagentless biosensor was used with amperometry in stirred solution at an applied potential of +0.1 V (vs. Ag/AgCl). All experiments were carried out at the following conditions: pH 7, temperature 37 °C, atmosphere 5% CO2. The linear range of the device was found to be 25-125 µM in phosphate buffer (75 mM, containing 0.05 M NaCl) and 25-150 µM in cell culture medium. The limits of detection (LOD) were found to be 1.2 µM and 4.2 µM based on three times signal to noise, using PBS and culture medium respectively. The sensitivity was calculated to be 106 nA µM(-1) cm(-2) and 210 nA µM(-1) cm(-2) in PBS and cell medium respectively. The response time was ∼60 s in an agitated solution. HepG2 cells were exposed to various concentrations of paracetamol (1 mM, 5 mM and 10 mM) in order to investigate the drug-induced release of glutamate into the culture medium in real time. Two toxicity studies were investigated using different methods of exposure and analysis. The first method consisted of a single measurement of the glutamate concentration, using the method of standard addition, after 24 h incubation. The concentrations of glutamate were found to be 52 µM, 93 µM and 177 µM, released on exposure to 1 mM, 5 mM and 10 mM paracetamol respectively. The second method involved the continuous monitoring of glutamate released from HepG2 cells upon exposure to paracetamol over 8 h. The concentrations of glutamate released in the presence of 1 mM, 5 mM and 10 mM paracetamol, increased in proportion to the drug concentration, ie: 16 µM, 28 µM and 62 µM respectively. This result demonstrates the feasibility of using this approach to monitor early metabolic changes after exposure to a model toxic compound.

A microband lactate biosensor fabricated using a water-based screen-printed carbon ink.

The present study demonstrated for the first time that screen-printed carbon microband electrodes fabricated from water-based ink can readily detect H(2)O(2) and that the same ink, with the addition of lactate oxidase, can be used to construct microband biosensors to measure lactate. These microband devices were fabricated by a simple cutting procedure using conventional sized screen-printed carbon electrodes (SPCEs) containing the electrocatalyst cobalt phthalocyanine (CoPC). These devices were characterised with H(2)O(2) using several electrochemical techniques. Cyclic voltammograms were found to be sigmoidal; a current density value of 4.2 mA cm(-2) was obtained. A scan rate study revealed that the mass transport mechanism was a mixture of radial and planar diffusion. However, a further amperometric study under quiescent and hydrodynamic conditions indicated that radial diffusion predominated. A chronoamperometric study indicated that steady-state currents were obtained with these devices for a variety of H(2)O(2) concentrations and that the currents were proportional to the analyte concentration. Lactate microband biosensors were then fabricated by incorporating lactate oxidase into the water-based formulation prior to printing and then cutting as described. Voltammograms demonstrated that lactate oxidase did not compromise the integrity of the electrode for H(2)O(2) detection. A potential of +400 mV was selected for a calibration study, which showed that lactate could be measured over a dynamic range of 1-10mM which was linear up to 6mM; a calculated lower limit of detection of 289 microM was ascertained. This study provides a platform for monitoring cell metabolism in-vitro by measuring lactate electrochemically via a microband biosensor.

Novel variable volume injector for performing sample introduction in a miniaturised isotachophoresis device.

A microdevice design furnished with a novel sample injector, capable of delivering variable volume samples, for miniaturised isotachophoretic separations is presented. Micromachining by direct milling was used to realise two flow channel network designs on poly(methyl methacrylate) chips. Both designs comprised a wide bore sample channel interfaced, via a short connection channel, to a narrow bore separation channel. Superior injection performance was observed with a connection channel angled at 45 degrees to the separation channel compared to a device using a channel angled at 90 degrees. Automated delivery of electrolytes to the microdevice was demonstrated with both hydrostatic pumping and syringe pumps; both gave reproducible sample injection. A range of different sampling strategies were investigated. Isotachophoretic separations of model analytes (metal ions and an anionic dye) demonstrated the potential of the device. Separations of ten metal cations were achieved in under 475 s.

Integrated moulded polymer electrodes for performing conductivity detection on isotachophoresis microdevices.

The feasibility of using integrated injection moulded polymer electrodes as drive and detection electrodes for performing miniaturised isotachophoresis (ITP) separations with conductivity detection has been demonstrated. Injection moulded electrodes were produced from three different grades of carbon-filled polymer. Two of the electrode designs were found to be suitable for performing on-chip conductivity detection. The high-voltage characteristics of the microdevices were found to be suitable for performing ITP, with a power dissipation up to 1.4 W m(-1) being achieved. Three model separations are presented to demonstrate the separation capability of the miniaturised injection moulded devices. Three anionic dyes, two inorganic anions and a mixture of eight alkaline earth, transition and lanthanide metal cations were analysed.

Mercury film electrodes: developments, trends and potentialities for electroanalysis.

In this article, the field of mercury film electrodes (MFE's) as electroanalytical devices is reviewed. Special emphasis is placed on the area of new materials as substrates for the mercury coating and the mercury plating process as well as on the developments related to the electrode modification used to achieve an increase in either the selectivity and/or the sensitivity of the analysis. Other topics discussed are microelectrodes, disposable electrodes and some novel, innovative or less well explored applications of electroanalytical methods using MFE's. The future prospects, potential uses and alternatives for MFE's in electroanalysis are finally discussed.

Determination of metal cations on miniaturised planar polymeric separation devices using isotachophoresis with integrated conductivity detection.

The feasibility of using miniaturised planar polymeric separation devices for the isotachophoretic separation of metal cations was demonstrated. Devices were produced in silicone rubber using a cast moulding fabrication technique. Detection was performed using an integrated single electrode conductivity detector, a design which offers simple fabrication and high resolution. The electrical characteristics of the devices were found to be suitable for performing electroseparations with a power dissipation of up to 1.5 W m-1 being achieved. The separation of a sample containing a mixture of the four metal ions lithium, lanthanum, dysprosium and ytterbium was reproducibly achieved using miniaturised devices. A comparison with a capillary scale separation of the same mixture was made. The miniaturised separations were achieved in under 600 s, which is less than half the time taken for the capillary scale separations.

Determination of Co(II) by chemiluminescence after in situ electrochemical pre-separation on a flow-through mercury film electrode.

A novel method of electrochemical pre-separation of Co(II) before detection by chemiluminescence is reported together with the associated instrumentation. The Co(II) ions were selectively pre-separated on a mercury film electrode (MFE) by on-line reduction, then the accumulated metal was oxidised and selectively stripped back into the flowing solution as Co(II). These secondary ions were quantified as a result of their catalytic activity on the chemiluminescent reaction between luminol and hydrogen peroxide that was also induced on-line. The whole sequence was carried out in an automated flow-through system, in which the electrochemical pre-separation of metals was performed in either continuous flow or flow injection analysis (FIA) regimes. The scope of the method, both in terms of selectivity and sensitivity, has been demonstrated and the quantitative determination of Co(II) by the proposed method has been investigated. For a period of continuous flow pre-separation of 4 min, the calibration curve for Co(II) was linear up to a concentration of 100 micrograms l-1, the relative standard deviation was 4% at the 20 micrograms l-1 level and the limit of detection was 0.5 microgram l-1 (at the 3 sigma level). The method was applied to the determination of the cobalt content in a high purity iron sample.

Development of a green fluorescent protein reporter for a yeast genotoxicity biosensor.

A reporter system, constructed for a laboratory screen for new genes involved in DNA repair in the brewer's yeast Saccharomyces cerevisiae, has been developed for use in a genotoxicity biosensor. The strain produces green fluorescent protein (yEGFP) when DNA damage has occurred. yEGFP is codon optimised for yeasts. The reporter does not respond to chemicals which delay mitosis, and responds appropriately to the genetic regulation of DNA repair. Data is presented which demonstrate strain improvements appropriate to biosensor technology: improved signal to noise ratio, ease of data collection and uncomplicated material handling.

Selective determination of Ni(II) and Co(II) by flow injection analysis and adsorptive cathodic stripping voltammetry on a wall jet mercury film electrode.

Ni(II) and Co(II) have been determined simultaneously by means of adsorptive cathodic stripping voltammetry (AdCSV) in a computerised flow injection system. The working electrode was a glassy carbon disk that was fitted in a wall-jet flow cell. The electrode was initially electrochemically coated with a mercury film at -1.0 V by injecting a Hg(II) solution in the flow stream. Then, the sample, containing Ni(II) and Co(II), was mixed on-line with a solution containing dimethylgyoxime (DMG) at pH 9 in order to selectively complex the metal ions and was injected in the flow system. After a number of successive injections during which accumulation took place under controlled potentiostatic conditions, the surface-bound complexes were reduced in ammonia buffer at pH 9 by a cathodic scan of the potential of the working electrode in the square wave mode and the current-potential response was recorded. Finally, the electrode surface was regenerated by a potentiostatic polarisation at -1.4 V in the same buffer. The apparatus could be easily converted for continuous flow accumulation in order to increase the sensitivity; in this mode of operation, instead of performing discrete injections, the sample was continuously pumped through the cell. Various parameters associated with the preconcentration, stripping and regeneration steps were optimised for the determination of Ni(II) and Co(II). The selectivity of the method was demonstrated for the analysis of high purity iron; the accuracy for the determination of Ni(II) and Co(II) was 11 and 3%, respectively while the coefficient of variation was 10 and 8%, respectively.

Simultaneous determination of vitamins A and E and carotenoids in plasma by reversed-phase HPLC in elderly and younger subjects.

A reversed-phase high-performance liquid-chromatographic method for the simultaneous determination of retinol, alpha-tocopherol, alpha-carotene, beta-carotene, cryptoxanthin, lutein/zeaxanthin, and lycopene is described. This method was applied to plasma measurements in healthy young and elderly subjects. The plasma, deproteinized with ethanol, is extracted twice with n-hexane. After evaporation, the residue is dissolved in 50 microL of tetrahydrofuran and made up to 200 microL with ethanol. Samples (50 microL) are injected onto a 250 x 4.6 mm column of 5-microns-particle Spherisorb ODS1 (Phase Separations) that had been equilibrated with solvent mixture A:B (90:10 by vol) [A = 100 mmol/L ammonium acetate in methanol: acetonitrile (80:20 by vol) and B = 100 mmol/L ammonium acetate in water] at 2 mL/min. The analytes are eluted by running a 12-min linear gradient to 100% A; solvent A is then maintained for 10 min. Intrabatch CVs were 2.3%, 3.3%, 2.8%, 3.6%, 3.6%, and 3.0% for retinol, alpha-tocopherol, lutein/zeaxanthin, cryptoxanthin, lycopene, and beta-carotene, respectively. The corresponding interbatch CVs were 4.9%, 5.8%, 12.3%, 6.5%, 8.0%, and 3.4%.

Bedside measurement of creatine kinase to guide thrombolysis on the coronary care unit.

Thrombolysis is effective in treating patients with acute myocardial infarction when started within 12 h of onset, and thus is in widespread use. Early diagnosis is essential but some patients admitted to the coronary care unit with myocardial infarction do not meet the diagnostic criteria on arrival, and thus do not undergo thrombolysis. We studied 117 patients admitted consecutively to our coronary care unit with suspected but unproven myocardial infarction; normally none would have received thrombolytic agents. In each patient creatine kinase levels were measured on admission and after intervals by nurses using capillary blood samples and a dry chemistry system. Infarction was subsequently confirmed in 29 patients. Of these, 17 (59%) were correctly diagnosed and underwent thrombolysis within 12 h on the basis of a raised creatine kinase measured at the bedside. Our findings suggest that use of a bedside assay by nurses allows additional patients with myocardial infarction to receive the benefit of thrombolytic therapy within the first 12 h.

Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease.

In a case/control study, serum concentrations of vitamins A and E and major carotenoids were determined in patients with Alzheimer's disease, multi-infarct dementia and control subjects. The results showed that both Alzheimer's and multi-infarct dementia patients had significantly lower levels of vitamin E and beta-carotene than controls (vitamin E: 18.65 +/- 3.62 mumol/l in Alzheimer's disease and 15.80 +/- 6.93 mumol/l in multi-infarct dementia versus 30.03 +/- 12.03 mumol/l in controls; beta-carotene less than 0.13 to 0.42 mumol/l in Alzheimer's disease and less than 0.13 to 0.30 mumol/l in multi-infarct dementia versus 0.13 to 1.53 mumol/l in controls). Vitamin A was significantly reduced only in the Alzheimer's patients (1.56 +/- 0.78 mumol/l in Alzheimer's disease versus 2.13 +/- 0.86 mumol/l in controls).

Low dose guar in a novel food product: improved metabolic control in non-insulin-dependent diabetes.

Sixteen non-insulin-dependent diabetic patients, mean age 60 years (range 47-69 years) and duration of diabetes 9 years (2-20 years), completed a randomized cross-over study of three 6-week periods separated by 2-week intervals to minimize carry-over effects, in which their usual bread was replaced by either control bread, guar bread (100 g guar/kg wheat flour), or control bread plus a guar granulate. The mean (+/- SEM) intake of guar taken in bread was 7.6 +/- 0.7 g/day (range 3.1-14.3 g/day). The granulate was taken in a dose of 5 g twice daily which provided 8.3 g guar/day. Significant reductions were found in glycosylated haemoglobin after guar bread (11.5 +/- 0.8% to 10.7 +/- 0.8%; p less than 0.02) and after guar granulate (11.2 +/- 0.8% to 10.6 +/- 0.7%; p less than 0.05) compared with control bread. Total cholesterol was also reduced significantly after both guar bread and guar granulate (p less than 0.01, p less than 0.02), the changes being due to LDL-cholesterol. Dietary intakes and body weight did not change. No significant side-effects were reported; 14 subjects found guar bread more palatable than guar granulate but 8 preferred the granulate for its convenience. We conclude that a lower than convential dose of guar can be effective and palatable. The incorporation of guar into food increases its metabolic benefits and palatability.